JP2021519313A5 - - Google Patents

Info

Publication number
JP2021519313A5
JP2021519313A5 JP2020551976A JP2020551976A JP2021519313A5 JP 2021519313 A5 JP2021519313 A5 JP 2021519313A5 JP 2020551976 A JP2020551976 A JP 2020551976A JP 2020551976 A JP2020551976 A JP 2020551976A JP 2021519313 A5 JP2021519313 A5 JP 2021519313A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
subject
crystal type
cyanophenyl
Prior art date
Application number
JP2020551976A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519313A (ja
JPWO2019184897A5 (https=
JP7357634B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2018/080889 external-priority patent/WO2019183835A1/en
Application filed filed Critical
Publication of JP2021519313A publication Critical patent/JP2021519313A/ja
Publication of JPWO2019184897A5 publication Critical patent/JPWO2019184897A5/ja
Publication of JP2021519313A5 publication Critical patent/JP2021519313A5/ja
Application granted granted Critical
Publication of JP7357634B2 publication Critical patent/JP7357634B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020551976A 2018-03-28 2019-03-26 Ｕｒａｔ－１阻害剤の新規塩型 Active JP7357634B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/080889 2018-03-28
PCT/CN2018/080889 WO2019183835A1 (en) 2018-03-28 2018-03-28 Novel salt forms of urat-1 inhibitors
PCT/CN2019/079619 WO2019184897A1 (en) 2018-03-28 2019-03-26 Novel salt forms of urat-1 inhibitors

Publications (4)

Publication Number Publication Date
JP2021519313A JP2021519313A (ja) 2021-08-10
JPWO2019184897A5 JPWO2019184897A5 (https=) 2022-03-22
JP2021519313A5 true JP2021519313A5 (https=) 2022-03-22
JP7357634B2 JP7357634B2 (ja) 2023-10-06

Family

ID=68059457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551976A Active JP7357634B2 (ja) 2018-03-28 2019-03-26 Ｕｒａｔ－１阻害剤の新規塩型

Country Status (10)

Country Link
US (2) US11339127B2 (https=)
EP (1) EP3774733B1 (https=)
JP (1) JP7357634B2 (https=)
KR (1) KR102907394B1 (https=)
CN (1) CN111902398B (https=)
AU (1) AU2019241202B2 (https=)
CA (1) CA3094292A1 (https=)
IL (1) IL277578A (https=)
TW (1) TWI818001B (https=)
WO (2) WO2019183835A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234060B (zh) * 2021-04-30 2022-11-08 山东大学 一种稠杂环吡啶巯乙酸类衍生物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081930A1 (es) * 2010-06-16 2012-10-31 Ardea Biosciences Inc Compuestos de tioacetato
TWI499412B (zh) * 2010-06-16 2015-09-11 亞德生化公司 苯基硫乙酸酯組合物及其使用方法
US8549908B2 (en) * 2010-06-17 2013-10-08 Los Robles Advertising, Inc. Thermal anemometer flow meter for the measurement of wet gas flow
CN105439946B (zh) * 2014-08-13 2018-02-02 益方生物科技（上海）有限公司 羧酸化合物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2014532726A5 (https=)
US8372872B2 (en) Methods for concomitant treatment of theophylline and febuxostat
JP2020508338A5 (https=)
JP2021519313A5 (https=)
US9399036B2 (en) Methods of colchicine administration
JPWO2019184897A5 (https=)
US20240293369A1 (en) Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid
EP2568982B1 (en) Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof
JP2022541482A (ja) ベリヌラドを含む用量ダンピング耐性医薬組成物
US20240415814A1 (en) Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid
JP2013526499A (ja) キサンチンオキシダーゼ阻害剤およびスタチンの合剤およびその使用
JPH1192377A (ja) 免疫調節用医薬組成物
WO2002072099A1 (en) Therapeutic and/or preventive agent for diabetic ischemic heart disease
WO2007069669A1 (ja) アディポネクチン産生を増強する医薬組成物